Idera Pharmaceuticals Inc (NASDAQ:IDRA)

1.89
Delayed Data
As of May 24
 -0.02 / -1.05%
Today’s Change
1.32
Today|||52-Week Range
2.87
-10.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-38.6M-48.6M-38.4M-66.0M
 
 
 
 
 
Depreciation206.0K488.0K656.0K746.0K
 
 
 
 
 
Total Other Cash Flow4.6M6.3M7.6M11.0M
 
 
 
 
 
Funds From Operations-33.8M-41.8M-30.1M-54.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.5M1.2M-1.9M985.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-31.3M-43.0M-28.2M-55.3M
 
 
 
 
 
 
InvestingIncrease In Investments-23.6M-63.1M-2.9M0.00
 
 
 
 
Decrease In Investments4.1M30.4M34.7M28.3M
 
 
 
 
 
Capital Expenditures-1.1M-727.0K-408.0K-206.0K
 
 
 
 
 
Net Cash Flow Investing-20.6M-33.4M31.4M28.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-10.0K-7.0K-11.0K
 
 
 
 
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-5.0K-120.0K-261.0K-292.0K
 
 
 
 
 
Net Proceeds Stock Sale46.4M83.1M51.2M59.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total-798.0K0.000.000.00
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing45.6M83.0M50.9M59.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-6.3M6.6M54.1M32.0M